A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 43 (3), 321-326
- https://doi.org/10.1016/j.transci.2010.10.001
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The role of pegfilgrastim in mobilization of hematopoietic stem cellsTransfusion and Apheresis Science, 2008
- Pharmacokinetics of PegfilgrastimPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for LymphomaJournal of Clinical Oncology, 2003
- Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast CancerJournal of Clinical Oncology, 2002
- PegfilgrastimDrugs, 2002
- Autologous Transplantation for Diffuse Aggressive Non-Hodgkin’s Lymphoma in Patients Never Achieving Remission: A Report from the Autologous Blood and Marrow Transplant RegistryJournal of Clinical Oncology, 2001
- 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice GuidelinesJournal of Clinical Oncology, 2000
- Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's DiseaseBlood, 1997
- The ISHAGE Guidelines for CD34+ Cell Determination by Flow CytometryJournal of Hematotherapy, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995